2-[5-[[[tert-butyl(dimethyl)silyl]amino]sulfonimidoyl]-2-methylthiophen-3-yl]propan-2-ol
C14H28N2O2S2Si — CID 151374522
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[5-[[[tert-butyl(dimethyl)silyl]amino]sulfonimidoyl]-2-methylthiophen-3-yl]propan-2-ol
2-[5-[[[tert-butyl(dimethyl)silyl]amino]sulfonimidoyl]-2-methylthiophen-3-yl]propan-2-ol (PubChem CID 151374522) has the molecular formula C14H28N2O2S2Si and a molecular weight of 348.61 g/mol. Its IUPAC name is 2-[5-[[[tert-butyl(dimethyl)silyl]amino]sulfonimidoyl]-2-methylthiophen-3-yl]propan-2-ol.
Molecular Properties
| Compound Name | 2-[5-[[[tert-butyl(dimethyl)silyl]amino]sulfonimidoyl]-2-methylthiophen-3-yl]propan-2-ol |
|---|---|
| PubChem CID | 151374522 |
| Molecular Formula | C14H28N2O2S2Si |
| Molecular Weight | 348.61 g/mol |
| Exact Mass | 348.14 |
| IUPAC Name | 2-[5-[[[tert-butyl(dimethyl)silyl]amino]sulfonimidoyl]-2-methylthiophen-3-yl]propan-2-ol |
| SMILES | [H]N=S(=O)(N[Si](C)(C)C(C)(C)C)c1cc(C(C)(C)O)c(C)s1 |
| InChI | InChI=1S/C14H28N2O2S2Si/c1-10-11(14(5,6)17)9-12(19-10)20(15,18)16-21(7,8)13(2,3)4/h9,17H,1-8H3,(H2,15,16,18) |
| InChIKey | ORDKMOOQBPMCTB-UHFFFAOYSA-N |
| XLogP | 4.20 |
| TPSA | 73.18 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 348.61 |
| LogP ≤ 5 | 4.20 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 151374522 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.